Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Lein

Showing results (71-80 of 106) with videos related to

Pageof 11
Sort By:
Clinical Chemistry and Laboratory Medicine|October 3, 2014
Urinary thiosulfate as failed prostate cancer biomarker - an exemplary multicenter re-evaluation studyCarsten Stephan, Jacek Wilkosz, Waldemar Różański, et al.
Cancer Letters|March 24, 2004
Increased cell-free DNA in plasma of patients with metastatic spread in prostate cancerKlaus Jung, Carsten Stephan, Michaela Lewandowski, et al.
Cancer|July 12, 2005
The ratio of prostate-specific antigen (PSA) to prostate volume (PSA density) as a parameter to improve the detection of prostate carcinoma in PSA values in the range of < 4 ng/mLCarsten Stephan, Greta Stroebel, Marc Heinau, et al.
BJU International|March 16, 2007
Different prostate-specific antigen assays give different results on the same blood sample: an obstacle to recommending uniform limits for prostate biopsiesCarsten Stephan, Jürgen Kramer, Hellmuth-Alexander Meyer, et al.
BJU International|June 8, 2012
Long-term oncological and continence outcomes after laparoscopic radical prostatectomy: a single-centre experienceJonas Busch, Carsten Stephan, Anja Herold, et al.
World Journal of Urology|May 12, 2012
Impact of positive surgical margins on oncological outcome following laparoscopic radical prostatectomy (LRP): long-term resultsJonas Busch, Carsten Stephan, Annett Klutzny, et al.
Investigational New Drugs|July 13, 2011
Effect of quinolinyl acrylate derivatives on prostate cancer in vitro and in vivoJuan R Rodrigues, Jaime Charris, Rosa Ferrer, et al.
Clinical Chemistry|May 26, 2011
Between-method differences in prostate-specific antigen assays affect prostate cancer risk prediction by nomogramsCarsten Stephan, Kerstin Siemssen, Henning Cammann, et al.
The Journal of Pharmacy and Pharmacology|January 30, 2013
N'-Formyl-2-(5-nitrothiophen-2-yl)benzothiazole-6-carbohydrazide as a potential anti-tumour agent for prostate cancer in experimental studiesJuan R Rodrigues, Jaime Charris, José Camacho, et al.
Anticancer Research|January 25, 2008
Transrectal broadband-Doppler sonography with intravenous contrast medium administration for prostate imaging and biopsy in men with an elevated PSA value and previous negative biopsiesKasra Taymoorian, Anke Thomas, Torsten Slowinski, et al.
Pageof 11

Showing results (71-80 of 106) with videos related to

Sort By:
Pageof 11
Clinical Chemistry and Laboratory Medicine|October 3, 2014
Urinary thiosulfate as failed prostate cancer biomarker - an exemplary multicenter re-evaluation studyCarsten Stephan, Jacek Wilkosz, Waldemar Różański, et al.
Cancer Letters|March 24, 2004
Increased cell-free DNA in plasma of patients with metastatic spread in prostate cancerKlaus Jung, Carsten Stephan, Michaela Lewandowski, et al.
Cancer|July 12, 2005
The ratio of prostate-specific antigen (PSA) to prostate volume (PSA density) as a parameter to improve the detection of prostate carcinoma in PSA values in the range of < 4 ng/mLCarsten Stephan, Greta Stroebel, Marc Heinau, et al.
BJU International|March 16, 2007
Different prostate-specific antigen assays give different results on the same blood sample: an obstacle to recommending uniform limits for prostate biopsiesCarsten Stephan, Jürgen Kramer, Hellmuth-Alexander Meyer, et al.
BJU International|June 8, 2012
Long-term oncological and continence outcomes after laparoscopic radical prostatectomy: a single-centre experienceJonas Busch, Carsten Stephan, Anja Herold, et al.
World Journal of Urology|May 12, 2012
Impact of positive surgical margins on oncological outcome following laparoscopic radical prostatectomy (LRP): long-term resultsJonas Busch, Carsten Stephan, Annett Klutzny, et al.
Investigational New Drugs|July 13, 2011
Effect of quinolinyl acrylate derivatives on prostate cancer in vitro and in vivoJuan R Rodrigues, Jaime Charris, Rosa Ferrer, et al.
Clinical Chemistry|May 26, 2011
Between-method differences in prostate-specific antigen assays affect prostate cancer risk prediction by nomogramsCarsten Stephan, Kerstin Siemssen, Henning Cammann, et al.
The Journal of Pharmacy and Pharmacology|January 30, 2013
N'-Formyl-2-(5-nitrothiophen-2-yl)benzothiazole-6-carbohydrazide as a potential anti-tumour agent for prostate cancer in experimental studiesJuan R Rodrigues, Jaime Charris, José Camacho, et al.
Anticancer Research|January 25, 2008
Transrectal broadband-Doppler sonography with intravenous contrast medium administration for prostate imaging and biopsy in men with an elevated PSA value and previous negative biopsiesKasra Taymoorian, Anke Thomas, Torsten Slowinski, et al.
Pageof 11